• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

116名努南综合征日本个体人体测量参数的遗传背景及基因型-表型关系

Genetic backgrounds and genotype-phenotype relationships in anthropometric parameters of 116 Japanese individuals with Noonan syndrome.

作者信息

Shoji Yasuko, Hata Ayaha, Maeyama Takatoshi, Wada Tamaki, Hasegawa Yuiko, Nishi Eriko, Ida Shinobu, Etani Yuri, Niihori Tetsuya, Aoki Yoko, Okamoto Nobuhiko, Kawai Masanobu

机构信息

Department of Gastroenterology and Endocrinology, Osaka Women's and Children's Hospital, Osaka, Japan.

Department of Epidemiology and Health Policy, University of Toyama, Toyama, Japan.

出版信息

Clin Pediatr Endocrinol. 2024;33(2):50-58. doi: 10.1297/cpe.2024-0005. Epub 2024 Feb 26.

DOI:10.1297/cpe.2024-0005
PMID:38572385
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10985011/
Abstract

Noonan syndrome (NS) is caused by pathogenic variants in genes encoding components of the RAS/MAPK pathway and presents with a number of symptoms, including characteristic facial features, congenital heart diseases, and short stature. Advances in genetic analyses have contributed to the identification of pathogenic genes in NS as well as genotype-phenotype relationships; however, updated evidence for the detection rate of pathogenic genes with the inclusion of newly identified genes is lacking in Japan. Accordingly, we examined the genetic background of 116 individuals clinically diagnosed with NS and the frequency of short stature. We also investigated genotype-phenotype relationships in the context of body mass index (BMI). Genetic testing revealed the responsible variants in 100 individuals (86%), where variants were the most prevalent (43%) and followed by (12%) and (9%). The frequency of short stature was the lowest in subjects possessing variants. No genotype-phenotype relationships in BMI were observed among the genotypes. In conclusion, this study provides evidence for the detection rate of pathogenic genes and genotype-phenotype relationships in Japanese patients with NS, which will be of clinical importance for accelerating our understanding of the genetic backgrounds of Japanese patients with NS.

摘要

努南综合征(NS)由编码RAS/MAPK通路成分的基因中的致病变异引起,表现出多种症状,包括特征性面部特征、先天性心脏病和身材矮小。基因分析的进展有助于确定NS中的致病基因以及基因型-表型关系;然而,在日本,缺乏纳入新发现基因后致病基因检测率的最新证据。因此,我们研究了116例临床诊断为NS的个体的遗传背景以及身材矮小的发生率。我们还在体重指数(BMI)的背景下研究了基因型-表型关系。基因检测在100例个体(86%)中发现了致病变异,其中 变异最为常见(43%),其次是 (12%)和 (9%)。身材矮小的发生率在携带 变异的受试者中最低。在各基因型之间未观察到BMI方面的基因型-表型关系。总之,本研究为日本NS患者致病基因的检测率和基因型-表型关系提供了证据,这对于加快我们对日本NS患者遗传背景的理解具有临床重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e21/10985011/ed41d6dde138/cpe-33-050-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e21/10985011/ed41d6dde138/cpe-33-050-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e21/10985011/ed41d6dde138/cpe-33-050-g001.jpg

相似文献

1
Genetic backgrounds and genotype-phenotype relationships in anthropometric parameters of 116 Japanese individuals with Noonan syndrome.116名努南综合征日本个体人体测量参数的遗传背景及基因型-表型关系
Clin Pediatr Endocrinol. 2024;33(2):50-58. doi: 10.1297/cpe.2024-0005. Epub 2024 Feb 26.
2
Molecular and clinical profile of patients referred as Noonan or Noonan-like syndrome in Greece: a cohort of 86 patients.希腊疑似诺南综合征或诺南样综合征患者的分子和临床特征:86 例患者的队列研究。
Eur J Pediatr. 2022 Oct;181(10):3691-3700. doi: 10.1007/s00431-022-04574-w. Epub 2022 Jul 29.
3
Genotype-phenotype correlation analysis in Japanese patients with Noonan syndrome.日本努南综合征患者的基因型-表型相关性分析。
Endocr J. 2019 Nov 28;66(11):983-994. doi: 10.1507/endocrj.EJ18-0564. Epub 2019 Jul 10.
4
Spectrum of mutations and genotype-phenotype analysis in Noonan syndrome patients with RIT1 mutations.RIT1 基因突变致 Noonan 综合征患者的突变频谱及基因型-表型分析。
Hum Genet. 2016 Feb;135(2):209-22. doi: 10.1007/s00439-015-1627-5. Epub 2015 Dec 29.
5
Molecular and clinical studies in 107 Noonan syndrome affected individuals with PTPN11 mutations.107 名诺南综合征患者 PTPN11 突变的分子和临床研究。
BMC Med Genet. 2020 Mar 12;21(1):50. doi: 10.1186/s12881-020-0986-5.
6
Genotype and phenotype in patients with Noonan syndrome and a RIT1 mutation.患有努南综合征且存在RIT1突变患者的基因型和表型。
Genet Med. 2016 Dec;18(12):1226-1234. doi: 10.1038/gim.2016.32. Epub 2016 Apr 21.
7
Molecular and phenotypic spectrum of Noonan syndrome in Chinese patients.中国患者努南综合征的分子和表型谱。
Clin Genet. 2019 Oct;96(4):290-299. doi: 10.1111/cge.13588. Epub 2019 Jul 10.
8
Expanding the clinical phenotype of RASopathies in 38 Turkish patients, including the rare LZTR1, RAF1, RIT1 variants, and large deletion in NF1.在 38 名土耳其患者中扩展 RASopathy 的临床表型,包括罕见的 LZTR1、RAF1、RIT1 变异体和 NF1 中的大片段缺失。
Am J Med Genet A. 2021 Dec;185(12):3623-3633. doi: 10.1002/ajmg.a.62410. Epub 2021 Jun 29.
9
Noonan syndrome: comparing mutation-positive with mutation-negative dutch patients.努南综合征:荷兰突变阳性与突变阴性患者的比较。
Mol Syndromol. 2013 Jun;4(5):227-34. doi: 10.1159/000350686. Epub 2013 May 8.
10
Noonan syndrome on the African Continent.非洲大陆的努南综合征。
Birth Defects Res. 2020 Jun;112(10):718-724. doi: 10.1002/bdr2.1675.

引用本文的文献

1
[Growth and development patterns of Noonan syndrome and advances in the treatment of short stature].[努南综合征的生长发育模式及矮小症治疗进展]
Zhongguo Dang Dai Er Ke Za Zhi. 2025 Jan 15;27(1):33-38. doi: 10.7499/j.issn.1008-8830.2409047.

本文引用的文献

1
The molecular genetics of RASopathies: An update on novel disease genes and new disorders.RAS 相关疾病的分子遗传学:新疾病基因和新疾病的最新进展。
Am J Med Genet C Semin Med Genet. 2022 Dec;190(4):425-439. doi: 10.1002/ajmg.c.32012. Epub 2022 Nov 16.
2
Molecular and clinical profile of patients referred as Noonan or Noonan-like syndrome in Greece: a cohort of 86 patients.希腊疑似诺南综合征或诺南样综合征患者的分子和临床特征:86 例患者的队列研究。
Eur J Pediatr. 2022 Oct;181(10):3691-3700. doi: 10.1007/s00431-022-04574-w. Epub 2022 Jul 29.
3
Expanding the clinical phenotype of RASopathies in 38 Turkish patients, including the rare LZTR1, RAF1, RIT1 variants, and large deletion in NF1.
在 38 名土耳其患者中扩展 RASopathy 的临床表型,包括罕见的 LZTR1、RAF1、RIT1 变异体和 NF1 中的大片段缺失。
Am J Med Genet A. 2021 Dec;185(12):3623-3633. doi: 10.1002/ajmg.a.62410. Epub 2021 Jun 29.
4
Phenotype-genotype analysis of 242 individuals with RASopathies: 18-year experience of a tertiary center in Brazil.242 例 RASopathy 患者的表型-基因型分析:巴西一家三级中心的 18 年经验。
Am J Med Genet C Semin Med Genet. 2020 Dec;184(4):896-911. doi: 10.1002/ajmg.c.31851. Epub 2020 Oct 31.
5
Young children with Noonan syndrome: evaluation of feeding problems.患有努南综合征的幼儿:喂养问题评估
Eur J Pediatr. 2020 Nov;179(11):1683-1688. doi: 10.1007/s00431-020-03664-x. Epub 2020 May 11.
6
Genotype-phenotype correlation analysis in Japanese patients with Noonan syndrome.日本努南综合征患者的基因型-表型相关性分析。
Endocr J. 2019 Nov 28;66(11):983-994. doi: 10.1507/endocrj.EJ18-0564. Epub 2019 Jul 10.
7
Molecular and phenotypic spectrum of Noonan syndrome in Chinese patients.中国患者努南综合征的分子和表型谱。
Clin Genet. 2019 Oct;96(4):290-299. doi: 10.1111/cge.13588. Epub 2019 Jul 10.
8
Delineation of LZTR1 mutation-positive patients with Noonan syndrome and identification of LZTR1 binding to RAF1-PPP1CB complexes.LZTR1 突变阳性的努南综合征患者的鉴定及 LZTR1 与 RAF1-PPP1CB 复合物结合的鉴定。
Hum Genet. 2019 Jan;138(1):21-35. doi: 10.1007/s00439-018-1951-7. Epub 2018 Oct 27.
9
C-type natriuretic peptide improves growth retardation in a mouse model of cardio-facio-cutaneous syndrome.C 型利钠肽可改善心面脂体综合征小鼠模型的生长迟缓。
Hum Mol Genet. 2019 Jan 1;28(1):74-83. doi: 10.1093/hmg/ddy333.
10
Noonan syndrome-causing SHP2 mutants impair ERK-dependent chondrocyte differentiation during endochondral bone growth.导致努南综合征的 SHP2 突变体在骺软骨生长过程中损害 ERK 依赖性软骨细胞分化。
Hum Mol Genet. 2018 Jul 1;27(13):2276-2289. doi: 10.1093/hmg/ddy133.